Please assess the completion status of the following clinical trial:

Trial Title: FIRE-PAD: Functional Improvement Through Revascularization of the Extremities for Peripheral Arterial Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:• Males and female between 40 and 85 years of age~* subjects referred to The Cleveland Clinic Foundation for a catheter-based revascularization procedure as treatment of intermittent claudication~* Leg symptoms consistent with intermittent claudication for a period of at least 3 months~* Ankle-brachial index (ABI) in the leg to be revascularized must be \< 0.90 or demonstration of post exercise fall in ABI to \< 0.9 for subjects with aortoiliac disease~* Subjects scheduled for both aortoiliac and/or femoropopliteal revascularization procedures will be eligible~* Subjects with bilateral leg symptoms may be enrolled, as long as bilateral revascularization procedures are planned~Exclusion Criteria:~* • Vascular anatomy inappropriate for a catheter-based procedure on the basis of non-invasive studies~  * Critical limb ischemia (rest pain, non-healing ulcer, gangrene)~ * Contraindication to contrast arteriography~ * Vascular surgery or prior catheter-based vascular intervention within the preceding 6 months~ * Patients with suspected or confirmed graft stenoses or occlusions~ * Myocardial infarction or hospitalization for unstable angina, coronary artery bypass grafting or percutaneous coronary intervention, within the preceding one month~ * Stroke or transient ischemic attack within the preceding one month~ * Pregnancy or planned pregnancy during the one year of participation in the trial.~ * Any active chronic inflammatory condition,including autoimmune disorder or active malignancy.Subjects unable to walk, amputees, and subjects with a contraindication to treadmill exercise.~ * Patients with dementia or other significant cognitive impairment~ * Patients who are non-English speaking, (due to the need for subjects to complete standardized questionnaires)

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).